Guideline for parenteral nutrition of the DGEM. Part 9: Technique and problems of access in parenteral nutrition;9 Technik und probleme der zugänge in der parenteralen ernährung

Aktuelle Ernahrungsmedizin

Volumn 32, Issue SUPPL. 1, 2007, Pages

  Jauch, K W ^a   Schregel, W ^a   Stanga, Z ^a   Bischoff, S C ^a   Brass P ^a   Hartl, W ^a   Muhlebach S ^a   Pscheidl, E ^a   Thul, P ^a   Volk, O ^a  

^a NONE

Author keywords

Application of central catheter; Catheter related infections; Central venous catheter; In line filter; Intravenous access

Indexed keywords

HIGH RISK PATIENT; HUMAN; MEDICAL SOCIETY; MORBIDITY; MORTALITY; OSMOLARITY; PARENTERAL NUTRITION; PRACTICE GUIDELINE; REVIEW; TECHNIQUE; TREATMENT INDICATION;

EID: 34447578845     PISSN: 03410501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (249)

1. Krzywda EA, Andris DA, Edmiston CE. Catheter infections: Diagnosis, etiology, treatment and prevention. Nutr Clin Pract 1999; 14: 178
2. Chung DH, Ziegler MM. Central venous catheter access. Nutrition 1998; 14: 119-123
3. Meadows N. Monitoring and complications of parenteral nutrition. Nutrition 1998; 14: 806-808
4. Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter. Ann Intern Med 1992; 116: 737-738
5. Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intravenous catheter use. Internal medicine house staff participate in a successful quality improvement project. Arch Intern Med 1994; 154: 1829-1832
6. Gebauer B, Teichgräber UK, Podrabsky P, Beck A, Wagner HJ. Ultraschall- und durchleuchtungs-gesteuerte Implantation peripher inserierter zentral-venöser Katheter (PICC). Fortschr Röntgenstr 2004; 176: 386-391
7. Duerksen DR, Papineau N, Siemens J, Yaffe C. Peripherally inserted central catheters for parenteral nutrition: a comparison with centrally inserted catheters. JPEN J Parenter Enteral Nutr 1999; 23: 85-89
8. Kumar M, Amin M. The peripherally inserted central venous catheter; friend or foe? Int J Oral Maxillofac Surg 2004; 33: 201-204
9. Nessler R. Special technique for the catheterization of "central" veins (Seldinger's or indirect technique). Prakt Anaesth 1978; 13: 99-102
10. Peters JL, Armstrong R. Air embolism occurring as a complication of central venous catheterization. Ann Surg 1978; 187: 375-378
11. Stow PJ, Burrows FA, Berthelsen PG, Stöber H, Durrant STS, Rahemtulla A et al. Central venous catheterisation. Lancet 1986; 328: 974-975
12. Belani KG, Buckley JJ, Gordon JR. Castaneda W. Percutaneous cervical central venous line placement: a comparison of the internal and external jugular vein routes. Anesth Analg 1980; 59: 40-44
13. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51: 1-29
14. Polderman KH, Girbes AR. Central venous catheter use. Part 2: infectious complications. Intensive Care Med 2002; 28: 18-28
15. Raad I, Umphrey J, Khan A, Truett LJ, Bodey GP. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect 1993; 23: 17-26
16. Richet H, Hubert B, Nitemberg G, Andremont A, Buu-Hoi A, Ourbak P et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990; 28: 2520-2525
17. Fuchs PC, Gustafson ME, King JT, Goodall PT. Assessment of catheter-associated infection risk with the Hickman right atrial catheter. Infect Control 1984; 5: 226-230
18. Thomas JH, MacArthur RI, Pierce GE, Hermreck AS. Hickman-Broviac catheters. Indications and results. Am J Surg 1980; 140: 791-796
19. Snydman DR, Murray SA, Kornfeld SJ, Majka JA, Ellis CA. Total parenteral nutrition-related infections. Prospective epidemiologic study using semiquantitative methods. Am J Med 1982; 73: 695-699
20. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402
21. Bjarnason K, Field J, Weston V, Stanga Z. Venesection for blood culture: trained nurses achieve same or lower contamination rates than doctors. Clin Nutr 2002; 21: 10
22. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002; 30: 476-489
23. Hanna HA, Raad I. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 2001; 22: 165-166
24. Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993; 33: 228-233
25. Timsit JF, Sebille V, Farkas JC, Misset B, Martin JB, Chevret S et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996; 276: 1416-1420
26. Shaffer JL, Bakker H, Bozzetti F, Ladefoged K, Leon-Sanz M, Messing B et al. A European survey on management of catheter-related complications in home parenteral nutrition. Clin Nutr 1997; 16: 42
27. Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J et al. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 1993; 153: 1791-1796
28. Chang L, Tsai JS, Huang SJ, Shih CC. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 2003; 31: 34-39
29. Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A et al. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol 2001; 22: 136-139
30. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA 1987; 258: 1777-1781
31. Matlow AG, Kitai I, Kirpalani H, Chapman NH, Corey M, Perlman M et al. A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy. Infect Control Hosp Epidemiol 1999; 20: 487-493
32. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr 1985; 9: 322-325
33. Nanninga AG, Vries EG de, Willemse PH, Oosterhuis BE, Sleijfer DT, Hoekstra HJ et al. Continuous infusion of chemotherapy on an outpatient basis via a totally implanted venous access port. Eur J Cancer 1991; 27: 147-149
34. Milani A, Vernizzi S, Passoni C, Sociale O, Macciola F, Grimaldi C et al. Huber needle in situ inpatients under continuous infusion chemotherapy: results of a study, Phase II. Prof Inferm 2000; 53: 71-74
35. Karamanoglu A, Yumuk PF, Gumus M, Ekenel M, Aliustaoglu M, Selimen D et al. Port needles: do they need to be removed as frequently in infusional chemotherapy? J Infus Nurs 2003; 26: 239-242
36. Mühlebach S, Fasolini F. 10 Jahre Ernährungsteam am Kantonsspital Aarau (KSA): Aufgaben, Entwicklungen, Erfahrungen. Viszeralchirurgie 2000; 35: 69-71
37. Quaglia MP La, Lucas A, Thaler HT, Friedlander-Klar H, Exelby PR, Groeger JS. A prospective analysis of vascular access device-related infections in children. J Pediatr Surg 1992; 27: 840-842
38. Miller K, Buchanan GR, Zappa S, Cochran C, Laufenberg J, Medeiros D et al. Implantable venous access devices in children with hemophilia: a report of low infection rates. J Pediatr 1998; 132: 934-938
39. Chatzinikolaou I, Zipf TF, Hanna H, Umphrey J, Roberts WM, Sherertz R et al. Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 2003; 36: 116-119
40. Ivanov R, Allen J, Calvin JE. The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: a meta-analysis. Crit Care Med 2000; 28: 615-619
41. Ruesch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versus subclavian access - a systematic review. Crit Care Med 2002; 30: 454-460
42. Bansmer G, Keith D, Tesluk H. Complications following use of indwelling catheters of inferior vena cava. JAMA 1958; 167: 1606-1611
43. Crane C. Venous interruption of septic thrombophlebitis. N Engl J Med 1960; 262: 947-951
44. Indar R. The dangers of indwelling polyethelene cannulae in deep veins. Lancet 1959; 1: 284-287
45. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998; 19: 842-845
46. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 2000; 117: 178-183
47. Mian NZ, Bayly R, Schreck DM, Besserman EB, Richmond D. Incidence of deep venous thrombosis associated with femoral venous catheterization. Acad Emerg Med 1997; 4: 1118-1121
48. Durbec O, Viviand X, Potie F, Vialet R, Albanese J, Martin C. A prospective evaluation of the use of femoral venous catheters in critically ill adults. Crit Care Med 1997; 25: 1986-1989
49. Merrer J, Jonghe B De, Golliot F, Lefrant JY, Raffy B, Barre E et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001; 286: 700-707
50. Trottier SJ, Veremakis C, O'Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Crit Care Med 1995; 23: 52-59
51. Harden JL, Kemp L, Mirtallo J. Femoral catheters increase risk of infection in total parenteral nutrition patients. Nutr Clin Pract 1995; 10: 60-66
52. Kemp L, Burge J, Choban P, Harden J, Mirtallo J, Flancbaum L. The effect of catheter type and site on infection rates in total parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1994; 18: 71-74
53. Sznajder JI, Zveibil FR, Bitterman H, Weiner P, Bursztein S. Central vein catheterization. Failure and complication rates by three percutaneous approaches. Arch Intern Med 1986; 146: 259-261
54. Mermel L. Central venous catheter-related infections and their prevention: is there enough evidence to recommend tunneling for short-term use? Crit Care Med 1998; 26: 1315-1316
55. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 91: 197S-205S
56. Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napolitano LM et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998; 158: 81-87
57. Richet H, Hubert B, Nitemberg G, Andremont A, Buu-Hoi A, Ourbak P et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990; 28: 2520-2525
58. Richards B, Chaboyer W, Bladen T, Schluter PJ. Effect of central venous catheter type on infections: a prospective clinical trial. J Hosp Infect 2003: 54: 10-17
59. Macdonald S, Watt AJ, McNally D, Edwards RD, Moss JG. Comparison of technical success and outcome of tunneled catheters inserted via the jugular and subclavian approaches. J Vasc Interv Radiol 2000; 11: 225-231
60. Rosen M, Latto IP, Shang Ng W. Handbook of percutaneous central venous catheterisation. London, Toronto, Philadelphia, Marrickville: WB Saunders Company Ltd, 1992
61. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut. Prevention Gefaßkatheterassoziierter Infektionen - Empfehlung der Kommission für Krankenhaushygiene und Infektionspravention beim Robert Koch-Institut (RKI). Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2002; 45: 904-927
62. Fletcher SJ, Bodenham AR. Safe placement of central venous catheters: where should the tipp of the catheter lie? Br J Anaesth 2000; 85: 188-191
63. Bozzetti F, Mariani L, Bertinet DB, Chiavenna G, Crose N, Cicco M De et al. Central venous catheter (CVC) complications in 447 pts on home parenteral nutrition (HPN). Clin Nutr 2001; 20: 31
64. Bozzetti F, Mariani L, Bertinet DB, Chiavenna G, Crose N. Cicco M De et al. Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100.000 catheter days. Clin Nutr 2002; 21: 475-485
65. Cowl CT, Weinstock JV, Al Jurf A, Ephgrave K, Murray JA, Dillon K. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters. Clin Nutr 2000; 19: 237-243
66. Duerksen DR, Papineau N, Siemens J, Yaffe C. Peripherally inserted central catheters for parenteral nutrition: a comparison with centrally inserted catheters. JPEN J Parenter Enteral Nutr 1999; 23: 85-89
67. Smith JR, Friedell ML, Cheatham ML, Martin SP, Cohen MJ, Horowitz JD. Peripherally inserted central catheters revisited. Am J Surg 1998; 176: 208-211
68. Ng PK, Ault MJ, Ellrodt AG, Maldonado L. Peripherally inserted central catheters in general medicine. Mayo Clin Proc 1997; 72: 225-233
69. Venkataraman ST, Thomson AE, Orr RA. Femoral vascular catheterisation in critically ill infants and children. Clin Pediatr 1997; 36: 311-319
70. Goldstein AM, Weber JM, Sheridan RL. Femoral venous access is safe in burned children: an analysis of 224 catheters. J Pediatr 1997; 130: 442-446
71. Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous femoral venous catheterizations: a prospective study of complications. J Pediatr 1989; 114: 411-415
72. Pomp A, Caldwell MD, Field J, Feitelson M, Varella L, Albina J. Seldinger technique for central venous catheter insertions, a prospective study of 200 cases. Clin Nutr 1987; 6: 103
73. Miller JA, Singireddy S, Maldjian P, Baker SR. A reevaluation of the radiographically detectable complications of percutaneous venous access lines inserted by four subcutaneous approaches. Am Surg 1999; 65: 125-130
74. Fisher KL, Leung AN. Radiographic appearance of central venous catheters. AJR Am J Roentgenol 1996; 166: 329-337
75. Caridi JG, West JH, Stavropoulos SW, Hawkins IF Jr. Internal jugular and upper extremity central venous access in interventional radiology: is a postprocedure chest radiograph necessary? AJR Am J Roentgenol 2000; 174: 363-366
76. Randolph AG, Cook DJ, Gonzales CA. Fribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med 1996; 24: 2053-2058
77. Brass P, Volk O, Leben J, Schregel W. Zentralvenöse Punktion - nur noch mit Ultraschall? Anasthesiol Intensivmed Notfallmed Schmerzther 2001 ; 36: 619-627
78. Keenan SP. Use of ultrasound to place central lines. J Crit Care 2002; 17: 126-137
79. Wagner HJ, Teichgräber U, Gebauer B, Kalinowski M. Transjugular implantation of venous port catheter systems. Rofo 2003; 175: 1539-1544
80. Hind D, Calvert N, McWilliams R, Davidson A, Paisley S, Beverley C et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003; 327: 361
81. Oguzkurt L, Tercan F, Kara G, Torun D, Kizilkilic O, Yildirim T. US-guided placement of temporary internal jugular vein catheters: immediate technical success and complications in normal and high-risk patients. Eur J Radiol 2005; 55: 125-129
82. Schäfer M, Reinhart K. Placement of central venous catheters using intra-arterial ECG recording. Zentralbl Chir 1993; 118: 432-435
83. McGee WT, Mallory DL, Johans TG et al. Safe placement of central venous catheters is facilitated using right atrial electrocardiography. Crit Care Med 1988; 16: 434
84. Fritz KW, Gras C, Logemann F, Kirchhoff K. Positioning the central venous catheter using intra-atrial ECG. Anaesthesiol Reanim 1991; 16: 399-402
85. Nakatani K, Nishikawa K, Funao T, Ikeda Y, Nakasuji K, Iida Y et al. Accurate placement of central venous catheter - ECG-guided method vs patient height method. Masui 2002; 51: 34-38
86. Madias JE. Intracardiac (superior vena cava/right atrial) ECGs using saline solution as the conductive medium for the proper positioning of the Shiley hemodialysis catheter: is it not time to forego [correction of forgo] the postinsertion chest radiograph? Chest 2003; 124: 2363-2367
87. Madias JE. Intracardiac electrocardiography via a "saline-filled central venous catheter electrocardiographic lead": a historical perspective. J Electrocardiol 2004; 37: 83-88
88. Schummer W, Herrmann S, Schummer C, Funke F, Steenbeck J, Fuchs J et al. Intra-atrial ECG is not a reliable method for positioning left internal jugular vein catheters. Br J Anaesth 2003; 91: 481-486
89. Watters VA, Grant JP. Use of electrocardiogram to position right atrial catheters during surgery. Ann Surg 1997; 225: 165-171
90. Chu KS, Hsu JH, Wang SS, Tang CS, Cheng KI, Wang CK et al. Accurate central venous port-A catheter placement: intravenous electrocardiography and surface landmark techniques compared by using transesophageal echocardiography. Anesth Analg 2004; 98: 910-4, table
91. Madan M, Shah MV, Alexander DJ, Taylor C, McMahon MJ. Right atrial electrocardiography: a technique for the placement of central venous catheters for chemotherapy or intravenous nutrition. Br J Surg 1994; 81: 1604-1605
92. McGee WT, Ackerman BL, Rouben LR, Prasad VM, Bandi V, Mallory DL. Accurate placement of central venous catheters: a prospective, randomized, multicenter trial. Crit Care Med 1993; 21: 1118-1123
93. Corsten SA, Dijk B van, Bakker NC, Lange JJ de, Scheffer GJ. Central venous catheter placement using the ECG-guided Cavafix-Certodyn SD catheter. J Clin Anesth 1994; 6: 469-472
94. Nachnani GH, Lessin LS, Motomiya T, Jensen WN. Scanning electron microscopy of thrombogenesis on vascular catheter surfaces. N Engl J Med 1972; 286: 139-140
95. Stillman RM, Soliman F, Garcia L, Sawyer PN. Etiology of catheter-associated sepsis. Correlation with thrombogenicity. Arch Surg 1977; 112: 1497-1499
96. Borow M, Crowley JG. Evaluation of central venous catheter thrombogenicity. Acta Anaesthesiol Scand Suppl 1985; 81: 59-64
97. Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 1983; 18: 1061-1063
98. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987; 258: 2396-2403
99. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med 1991; 114: 845-854
100. Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices. IV. Scanning electron microscopy of intravenous catheters invaded by yeasts. Zentralbl Bakteriol Mikrobiol Hyg [B] 1981; 173: 419-424
101. Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices. I. Microtopographical characteristics of intravenous catheters as detected by scanning electron microscopy. Zentralbl Bakteriol Mikrobiol Hyg [B] 1981; 173: 285-292
102. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32: 452-456
103. Marin MG, Lee JC, Skurnick JH. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Crit Care Med 2000; 28: 3332-3338
104. Carrasco MN, Bueno A, Cuerus C de las, Jimenez S, Salinas I, Sartorius A et al. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Med 2004; 30: 633-638
105. Foley PL, Barthel CH, Brausa HR. Effect of covalently bound heparin coating on patency and biocompatibility of long-term indwelling catheters in the rat jugular vein. Comp Med 2002; 52: 243-248
106. Nasuno A, Matsubara T, Hori T, Higuchi K, Tsuchida K, Mezaki T et al. Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome. Circ J 2003; 67: 96-98
107. Laster JL, Nichols WK, Silver D. Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies. Arch Intern Med 1989; 149: 2285-2287
108. Tokars JI, Cookson ST, McArthur MA, Boyer CL, McGeer AJ, Jarvis WR. Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med 1999; 131: 340-347
109. Gil RT, Kruse JA, Thill-Baharozian MC, Carlson RW. Triple- vs single-lumen central venous catheters. A prospective study in a critically ill population. Arch Intern Med 1989; 149: 1139-1143
110. Hilton E, Haslett TM, Borenstein MT, Tucci V, Isenberg HD, Singer C. Central catheter infections: single- versus triple-lumen catheters. Influence of guide wires on infection rates when used for replacement of catheters. Am J Med 1988; 84: 667-672
111. McCarthy MC, Shives JK, Robison RJ, Broadie TA. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. JPEN J Parenter Enteral Nutr 1987; 11: 259-262
112. Pemberton LB, Lyman B, Lander V, Covinsky J. Sepsis from triple- vs single-lumen catheters during total parenteral nutrition in surgical or critically ill patients. Arch Surg 1986; 121: 591-594
113. Ma TY, Yoshinaka R, Banaag A, Johnson B, Davis S, Berman SM. Total parenteral nutrition via multilumen catheters does not increase the risk of catheter-related sepsis: a randomized, prospective study. Clin Infect Dis 1998; 27: 500-503
114. Savage AP, Picard M, Hopkins CC, Malt RA. Complications and survival of multilumen central venous catheters used for total parenteral nutrition. Br J Surg 1993; 80: 1287-1290
115. Manglano R, Martin M. Safety of triple lumen catheters in the critically ill. Am Surg 1991; 57: 370-372
116. Attar A, Messing B. Evidence-based prevention of catheter infection during parenteral nutrition. Curr Opin Clin Nutr Metab Care 2001; 4: 211-218
117. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15: 231-238
118. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-343
119. Alonso-Echanove J, Edwards JR, Richards MJ, Brennan P, Venezia RA, Keen J et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 2003; 24: 916-925
120. Abi-Said D, Raad I, Umphrey J, Gonzalez V, Richardson D, Marts K et al. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol 1999; 20: 101-105
121. Humar A, Ostromecki A, Direnfeld J, Marshall JC, Lazar N, Houston PC et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000; 31: 1001-1007
122. Garland JS, Buck RK, Moloney P, Durkin DM, Toth-Lloyd S, Duffy M et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995; 14: 510-516
123. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 2002; 81: 466-479
124. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15: 95-102
125. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer 1997; 5: 485-488
126. Do AN, Ray BJ, Banerjee SN, Illian AF, Barnett BJ, Pham MH et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999; 179: 442-448
127. Gosbell IB. Central venous catheter related sepsis: epidemiology, pathogenesis, diagnosis, treatment and prevention. Int Care World 1994; 11: 54-59
128. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA 1992; 267: 2072-2076
129. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994; 22: 1729-1737
130. Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1999; 20: 618-620
131. Laura R, Degl'Innocenti M, Mocali M, Alberani F, Boschi S, Giraudi A et al. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian Nurse Bone Marrow Transplant Group (GITMO). Haematologica 2000; 85: 275-279
132. Madeo M, Martin CR, Turner C, Kirkby V, Thompson DR. A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive Crit Care Nurs 1998; 14: 187-191
133. Armstrong CW, Mayhall CG, Miller KB, Newsome HH Jr, Sugerman HJ, Dalton HP et al. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis 1986; 154: 808-816
134. Nehme AE. Nutritional support of the hospitalized patient. The team concept. JAMA 1980; 243: 1906-1908
135. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998; 158: 473-477
136. Tomford JW, Hershey CO. The i.v. therapy team: impact on patient care and costs of hospitalization. NITA 1985; 8: 387-389
137. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000; 132: 641-648
138. Ryan JA Jr, Abel RM, Abbott WM, Hopkins CC, Chesney TM, Colley R et al. Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients. N Engl J Med 1974; 290: 757-761
139. Sanders RA, Sheldon GF. Septic complications of total parenteral nutrition. A five year experience. Am J Surg 1976; 132: 214-220
140. Murphy LM, Lipman TO. Central venous catheter care in parenteral nutrition: a review. JPEN J Parenter Enteral Nutr 1987; 11: 190-201
141. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355: 1864-1868
142. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004; 30: 62-67
143. Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997; 25: 1417-1424
144. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic- impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997; 127: 257-266
145. Fraenkel D, Rickard C, Thomas P. Faoagali J, George N, Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006; 34: 668-675
146. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281: 261-267
147. Jaeger K, Zenz S, Juttner B, Ruschulte H, Kuse E, Heine J et al. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Ann Hematol 2005; 84: 258-262
148. Khare MD, Bukhari SS, Swann A, Spiers P, McLaren I, Myers J. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. J Infect. 2006 (in press)
149. Benezra D, Kiehn TE, Gold JW, Brown AE, Turnbull AD, Armstrong D. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 1988; 85: 495-498
150. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340: 1-8
151. Hanna HA, Raad II, Hackett B, Wallace SK, Price KJ, Coyle DE et al. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest 2003; 124: 1030-1038
152. Leon C, Ruiz-Santana S, Rello J, Torre MV de la, Valles J, Alvarez-Lerma F et al. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 2004; 30: 1891-1899
153. Yucel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A et al. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. J Antimicrob Chemother 2004; 54: 1109-1115
154. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999; 115: 1632-1640
155. Boswald M, Lugauer S, Regenfus A, Braun GG, Martus P, Geis C et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 1999; 27, Suppl 1: S56-S60
156. Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta JM et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005; 143: 570-580
157. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282: 554-560
158. Arenas-Marquez H, Anaya-Prado R, Barrera-Zepeda LM, Gonzalez-Ojeda A. Complications of central venous catheters. Curr Opin Clin Nutr Metab Care 2001; 4: 207-210
159. Bennegard K, Curelaru I, Gustavsson B, Linder LE, Zachrisson BF. Material thrombogenicity in central venous catheterization. I. A comparison between uncoated and heparin-coated, long antebrachial, polyethylene catheters. Acta Anaesthesiol Scand 1982; 26: 112-120
160. Mollenholt P, Eriksson I, Andersson T. Thrombogenicity of pulmonary-artery catheters. Intensive Care Med 1987; 13: 57-59
161. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 423-428
162. Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998; 101: 483-486
163. Couban S, Goodyear M, Burnett M, Dolan S, Wasi P, Barnes D et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005; 23: 4063-4069
164. Klerk CP, Smorenburg SM, Butter HR. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch Intern Med 2003; 163: 1913-1921
165. Verso M, Agnelli G, Bertoglio S, Somma FC di, Paoletti F, Ageno W et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057-4062
166. Bethune K, Allwood M, Grainger C, Wormleighton C. Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition 2001; 17: 403-408
167. Lumpkin MM. Safety alert: hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm 1994; 51: 1427-1428
168. Ball PA, Bethune KM, Fox JC et al. Particulate contamination in parenteral nutrition solutions, still cause for concern. Clin Nutr 1999; 18: 14
169. Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care 2003; 6: 319-325
170. Newall F, Ranson K, Robertson J. Use of in-line filters in pediatric intravenous therapy. J Intraven Nurs 1998; 21: 166-170
171. Krzywda EA. Predisposing factors, prevention, and management of central venous catheter occlusions. J Intraven Nurs 1999; 22: S11-S17
172. Monturo CA, Dickerson RN, Mullen JL. Efficacy of thrombolytic therapy for occlusion of long-term catheters. JPEN J Parenter Enteral Nutr 1990; 14: 312-314
173. Gale GB, O'Connor DM, Chu JY, Stanley D. Restoring patency of thrombosed catheters with cryopreserved urokinase. JPEN J Parenter Enteral Nutr 1984; 8: 298-299
174. Fraschini G, Jadeja J, Lawson M, Holmes FA, Carrasco HC, Wallace S. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol 1987; 5: 672-678
175. Rumsey KA, Richardson DK. Management of infection and occlusion associated with vascular access devices. Semin Oncol Nurs 1995; 11: 174-183
176. Camp-Sorrell D. Implantable ports: everything you always wanted to know. J Intraven Nurs 1992; 15: 262-273
177. Main J, Pennington CR. Catheter blockage with lipid during long-term parenteral nutrition. Br Med J 1984; 289: 734
178. Pennington CR, Pithie AD. Ethanol lock in the management of catheter occlusion. JPEN J Parenter Enteral Nutr 1987; 11: 507-508
179. Mühlebach S. Was der praktizierende Arzt vom Umgang mit Infusionen wissen muss. Praxis, Schweizerische Rundschau für Medizin 2001; 90: 546-548
180. Allwood MC, Kearney MC. Compatibility and stability of additives in parenteral nutrition admixtures. Nutrition 1998; 14: 697-706
181. Stennett DJ, Gerwick WH, Egging PK, Christensen JM. Precipitate analysis from an indwelling total parenteral nutrition catheter. JPEN J Parenter Enteral Nutr 1988; 12: 88-92
182. Shulman RJ, Reed T, Pitre D, Laine L. Use of hydrochloric acid to clear obstructed central venous catheters. JPEN J Parenter Enteral Nutr 1988; 12: 509-510
183. Duffy LF, Kerzner B, Gebus V, Dice J. Treatment of central venous catheter occlusions with hydrochloric acid. J Pediatr 1989; 114: 1002-1004
184. Goodwin ML. Using sodium bicarbonate to clear a medication precipitate from a central venous catheter. JVAN 1991; 1: 23
185. Holcombe BJ, Forloines-Lynn S, Garmhausen LW. Restoring patency of long-term central venous access devices. J Intraven Nurs 1992; 15: 36-41
186. Siegman-Igra V, Anglim AM, Shapiro DE, Adal KA, Strain BA, Farr BM. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997; 35: 928-936
187. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-1272
188. Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 2002; 162: 871-878
189. Rijnders BJ, Peetermans WE, Verwaest C, Wilmer A, Wijngaerden E van. Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med 2004; 30: 1073-1080
190. Krzywda EA, Edmiston CE Jr. Central venous catheter infections. Clinical aspects of microbial etiology and pathogenesis. J Infus Nurs 2002; 25: 29-35
191. Forchielli ML, Gura K, Anessi-Pessina E, Richardson D, Cai W, Lo CW. Success rates and cost-effectiveness of antibiotic combinations for initial treatment of central-venous-line infections during total parenteral nutrition. JPEN J Parenter Enteral Nutr 2000; 24: 119-125
192. Sitges-Serra A, Girvent M. Catheter-related bloodstream infections. World J Surg 1999; 23: 589-595
193. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004; 140: 18-25
194. Dobbins BM, Catton JA, Kite P, McMahon MJ, Wilcox MH. Each lumen is a potential source of central venous catheter-related bloodstream infection. Crit Care Med 2003; 31: 1688-1690
195. Raad J, Davis S, Becker M, Hohn D, Houston D, Umphrey J et al. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 1993; 153: 1791-1796
196. Mayhall CG. Diagnosis and management of infections of implantable devices used for prolonged venous access. Curr Clin Top Infect Dis 1992; 12: 83-110
197. Hodge D, Puntis JW. Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition. Arch Dis Child Fetal Neonatal Ed 2002; 87: F21-F24
198. Sherertz RJ, Heard SO, Raad II. Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997; 35: 641-646
199. Fidalgo S, Vazquez F, Mendoza MC, Perez F, Mendez FJ. Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. Rev Infect Dis 1990; 12: 520-528
200. Pollack PF, Kadden M, Byrne WJ, Fonkalsrud EW, Ament ME. One hundred patient years' experience with the Broviac silastic catheter for central venous nutrition. JPEN J Parenter Enteral Nutr 1981; 5: 32-36
201. Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 1992; 11: 675-682
202. Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992; 13: 215-221
203. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995; 155: 1161-1166
204. Rose HD. Venous catheter-associated candidemia. Am J Med Sci 1978; 275: 265-269
205. th Interscience Conference of Antimicrobial Agents and Chemotherapy. San Francisco, California: 1995
206. th Interscience Conference of Antimicrobial Agents and Chemotherapy. San Francisco, California: 1995
207. Strinden WD, Helgerson RB, Maki DG. Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management. Ann Surg 1985; 202: 653-658
208. Raviglione MC, Battan R, Pablos-Mendez A, Aceves-Casillas P, Mullen MP, Taranta A. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med 1989; 86: 780-786
209. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990; 89: 137-141
210. Lecciones JA, Lee JW, Navarro EE, Witebsky EG, Marshall D, Steinberg SM et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14: 875-883
211. O'Grady NP, Barie PS, Bartlett J, Bleck T, Garvey G, Jacobi J et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med 1998; 26: 392-408
212. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988; 12: 185-189
213. Andris DA, Krzywda EA, Edmiston CE, Krepel CJ, Gohr CM. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 1998; 14: 427-432
214. Krzywda EA, Andris DA, Edmiston CE Jr, Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol 1995; 16: 596-598
215. Guggenbichler JP, Berchtold D, Allerberger F, Bonatti H, Hager J, Pfaller W et al. In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci. Eur J Clin Microbiol Infect Dis 1992; 11: 408-415
216. Rao JS, O'Meara A, Harvey T, Breatnach F. A new approach to the management of Broviac catheter infection. J Hosp Infect 1992; 22: 109-116
217. Benoit JL, Carandang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995; 21: 1286-1288
218. Messing B, Man F, Colimon R, Thuillier F, Beliah M. Antibiotic-lock technique is an effective treatment of bacterial catheter-related sepsis during parenteral nutrition. Clin Nutr 1990; 9: 220-225
219. Gaillard JL, Merlino R, Pajot N, Goulet O, Fauchere JL, Ricour C et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr 1990; 14: 593-597
220. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8: 1591-1597
221. Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/ heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18: 1269-1278
222. Payne-James JJ, Khawaja HT. First choice for total parenteral nutrition: the peripheral route. JPEN J Parenter Enteral Nutr 1993; 17: 468-478
223. Hansell DT. Intravenous nutrition: the central or peripheral route? Int Ther Clin Mon 1989; 6/7: 184-190
224. Couse N, Pickford LR, Mitchell CJ, Macfie J. Total parenteral nutrition by peripheral vein - Substitute or supplement to the central venous route? A prospective trial. Clin Nutr 1993; 12: 213-216
225. Everitt NJ, Wong C, McMahon MJ. Peripheral infusion as the route of choice for intravenous nutrition: a prospective two year study. Clin Nutr 1996; 15: 69-74
226. Kohlhardt SR, Smith RC, Wright CR, Sucic KA. Fine-bore peripheral catheters versus central venous catheters for delivery of intravenous nutrition. Nutrition 1992; 8: 412-417
227. Everitt NJ, Madan M, Alexander DJ, McMahon MJ. Fine bore silicone rubber and polyurethane catheters for the delivery of complete intravenous nutrition via a peripheral vein. Clin Nutr 1993; 12: 261-265
228. Timmer JG, Schipper HG. Peripheral venous nutrition: the equal relevance of volume load and osmolarity in relation to phlebitis. Clin Nutr 1991; 10: 71-75
229. Kuwahara T, Asanami S, Tamura T, Kaneda S. Effects of pH and osmolality on phlebitic potential of infusion solutions for peripheral parenteral nutrition. J Toxicol Sci 1998; 23: 77-85
230. Kuwahara T, Asanami S, Kubo S. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition 1998; 14: 496-501
231. Gazitua R, Wilson K, Bistrian BR, Blackburn GL. Factors determining peripheral vein tolerance to amino acid infusions. Arch Surg 1979; 114: 897-900
232. Isaacs JW, Millikan WJ, Stackhouse J, Hersh T, Rudman D. Parenteral nutrition of adults with a 900 milliosmolar solution via peripheral veins. Am J Clin Nutr 1977; 30: 552-559
233. Acra SA, Rollins C. Principles and guidelines for parenteral nutrition in children. Pediatr Ann 1999; 28: 113-120
234. Kane KF, Cologiovanni L, McKiernan J, Panos MZ, Ayres RC, Longman MJ et al. High osmolality feedings do not increase the incidence of thrombophlebitis during peripheral i.v. nutrition. JPEN J Parenter Enteral Nutr 1996; 20: 194-197
235. Williams N, Wales S, Irving MH. Prolonged peripheral parenteral nutrition with an ultrafine cannula and low-osmolality feed. Br J Surg 1996; 83: 114-116
236. Everitt NJ, McMahon MJ. Influence of fine-bore catheter length on infusion thrombophlebitis in peripheral intravenous nutrition: a randomised controlled trial. Ann R Coll Surg Engl 1997; 79: 221-224
237. Madan M, Alexander DJ, McMahon MJ. Influence of catheter type on occurrence of thrombophlebitis during peripheral intravenous nutrition. Lancet 1992; 339: 101-103
238. Hecker JF. Potential for extending survival of peripheral intravenous infusions. BMJ 1992; 304: 619-624
239. Everitt NJ, McMahon MJ. Peripheral intravenous nutrition. Nutrition 1994; 10: 49-57
240. Kuwahara T, Asanami S, Tamura T, Kubo S. Experimental infusion phlebitis: importance of titratable acidity on phlebitic potential of infusion solution. Clin Nutr 1996; 15: 129-132
241. Hessov J, Bojsen-Mooller M. Experimental infusion thrombophlebitis. Importance of the pH of glucose solutions. Eur J Intensive Care Med 1976; 2: 97-101
242. Lai KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. Am J Infect Control 1998; 26: 66-70
243. Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998; 158: 151-156
244. Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol 2002; 23: 249-253
245. Shimandle RB, Johnson D, Baker M, Stotland N, Karrison T, Arnow PM. Safety of peripheral intravenous catheters in children. Infect Control Hosp Epidemiol 1999; 20: 736-740
246. Garland JS, Dunne WM Jr, Havens P, Hintermeyer M, Bozzette MA, Wincek J et al. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics 1992; 89: 1145-1150
247. Garland JS, Nelson DB, Cheah TE, Hennes HH, Johnson TM. Infectious complications during peripheral intravenous therapy with Teflon catheters: a prospective study. Pediatr Infect Dis J 1987; 6: 918-921
248. Nelson DB, Garland JS. The natural history of Teflon catheter-associated phlebitis in children. Am J Dis Child 1987; 141: 1090-1092
249. Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennett JV, Brachman PS (eds): Hospital infections. Philadelphia: Lippencott-Raven, 1998: 689-724